LATEST
Samfara acquired Chr. Olesen SynthesisnewBanner Capital agreed to acquire Seaway Plastics Engineering, MME Group, and Wright Engineered PlasticsnewDiversis Capital acquired Tideworks Technology®newBorletti Group acquired PinalliManna Tree acquired ZambeziAdvent agreed to acquire CONTPAQiGemspring Capital's TRG acquired FentronFusion Capital Partners acquired Pioneer Power GroupH.I.G. Capital acquired ArcoGTCR acquired TactacamArcLight Capital Partners acquired IATPCharlesbank Capital Partners acquired AireSpring
Carrywatch.
Follow @carrywatch
Closed1 Oct 2026, 23:00 PT

Samfara /
Chr. Olesen Synthesis

Samfara just bought Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance APIs.

PR Newswire · 1 Oct 2026Source
See the source Get deal alerts for Samfara Get deal alerts for Chr. Olesen Synthesis
01 / BuyerSamfara
Source: PR Newswire
“Samfara, a European life sciences investment firm, today announced that it has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners.”

Published 1 Oct 2026

Open the source
02 / SellerChr. Olesen and funds managed by Signet Healthcare Partners
Source: PR Newswire
“Samfara, a European life sciences investment firm, today announced that it has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners.”

Published 1 Oct 2026

Open the source
03 / TargetChr. Olesen Synthesis
Source: PR Newswire
“Samfara, a European life sciences investment firm, today announced that it has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners.”

Published 1 Oct 2026

Open the source
01

What happened

Samfara completed the acquisition from Chr. Olesen and funds managed by Signet Healthcare Partners, Samfara said Oct. 2, 2026. Financial terms were not disclosed, and Chief Executive Thomas Moestrup is investing alongside Samfara. [01]

02

Who is involved, and the source

Everything on this page comes from the source below, quoted word for word.

Buy side: Samfara
01 / Buy sideSamfara
01
Source · PR Newswire

Samfara just bought Chr. Olesen Synthesis, a Danish manufacturer of controlled-substance APIs.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by PR Newswire · Closed

    23:00 PT. The source this page is built from. Added to Carrywatch's records 12 minutes after the source was published.

    Open the source

  2. Announced

    “Olesen and funds managed by Signet Healthcare Partners, Samfara said Oct. 2, 2026”

    From the source

The same firms, in other deals

The firms' deal history and connections across other deals.

Carrywatch Pro

these firms's full profile is part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch is invite-only. An invite lets you make an account and buy Pro; it does not include Pro.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 3 firms · 1 personHover a name to see how it connects
This dealSamfara / Chr. Olesen SynthesisClosed · 1 Oct 2026
BuyerSamfaraTargetChr. Olesen SynthesisSellerChr. Olesen and funds managed by Signet Healthcare PartnersChief ExecutiveThomas Moestrup
This dealSamfara / Chr. Olesen Synthesis

Closed · Samfara acquired Chr. Olesen Synthesis from Chr. Olesen and funds managed by Signet Healthcare Partners (Closed, published 1 Oct 2026).

Announced 2 Oct 2026
Timeline
  1. Published by PR Newswire
  2. Announced
Hover or tap a name to see how it connects, and when
Deal Web as a list
Next / Profile

Thomas Moestrup

Chief Executive